Researchers say this new Trump rule could destroy American science as we know it. They’re fighting back
Scientists Sound Alarm Over New Trump Rule Targeting Federal Funding
Researchers say this new Trump rule – The White House has sparked widespread concern among researchers with its proposal to overhaul the way scientific grants are awarded, granting political appointees more authority over funding decisions. This shift has drawn criticism from experts across disciplines, who argue the rule could undermine the integrity of American science and its role in driving innovation. The move has been described as a potential threat to the peer review system, a cornerstone of federal research funding since the post-World War II era, and could reshape the priorities of scientific inquiry in the United States.
A Threat to Scientific Merit and Leadership
At the heart of the debate is the peer review process, which has long been trusted to evaluate the quality and relevance of research proposals. By allowing political figures to override expert judgment, the rule risks replacing objective scientific criteria with partisan preferences. Critics warn that this could lead to a decline in the U.S.’s global scientific reputation, which has been built on decades of merit-based funding.
“Putting uninformed political hacks in charge of it is deeply stupid,” said Kate Marvel, a climate scientist who left NASA citing political interference. “The system wasn’t perfect, but it wasn’t stupid.”
Marvel’s departure highlights the growing tension between scientific autonomy and political control. She emphasized that the peer review system has been instrumental in advancing breakthroughs across fields, from climate science to artificial intelligence. Other experts, including Lisa Larrimore Ouellette, a professor at Stanford Law School, stress that the rule applies beyond research, affecting grants to state and local governments. “This proposal does not just apply to scientific research funding,” Ouellette noted. “It applies to other federal awards in all kinds of contexts.”
Key Changes and Potential Impacts
The Office of Management and Budget (OMB) has proposed several sweeping changes, including the elimination of research on diversity, equity, and inclusion, as well as studies focused on gender. These adjustments could alter the scope of scientific inquiry, potentially sidelining important topics that influence policy and public health. Additionally, the rule aims to halt federal collaborations with international scientific partners, a move that might weaken the U.S.’s role in global research efforts.
According to OMB officials, the goal is to bring transparency to the grantmaking process and ensure taxpayer dollars are allocated efficiently. They argue that federal grants have become politicized to support a far-left agenda, and the new framework would restore balance. However, scientists counter that this shift could prioritize short-term political goals over long-term scientific discovery. “Eliminating addiction research on the basis of race, ethnicity, or gender is not an abstract concept,” said Diane Fishbein of the Addiction Science Defense Network. “It could be devastating to real-world people struggling with addiction.”
Efforts to Counter the Rule
As the OMB proposal undergoes a public comment period, researchers, journals, and advocacy groups are rallying to oppose it. Elizabeth Ginexi, a former senior program officer at the National Institutes of Health, described the effort as a “longshot attempt to trigger Congressional review.” Her goal is to mobilize a broad coalition of scientists, patients, and science enthusiasts to submit comments, ensuring the administration must address them before finalizing the rule.
“Is this clinical trial ready for prime time? Is the molecular biology correct? Who should be making that decision—other scientists, oncologists, or do you want Russell Vought and Donald Trump making that decision?”
Ginexi’s perspective is informed by her experience with the Department of Government Efficiency, which she says has been slashing programs across the federal government. She left the NIH after 20 years, noting the administration’s focus on reducing funding and streamlining processes. “When we’re trying to come up with new clinical trials to test out a new therapeutic for a rare form of cancer, we want the scientists to be judging the merit of those applications,” she explained. “The system’s strength has long been attributed to its independence, but now it’s under threat.”
Broader Implications for Research
The proposed rule’s reach extends beyond traditional scientific fields, impacting areas like climate science, public health, and technology development. For example, the changes could reduce funding for climate research, which has been critical in understanding global warming and its effects. Similarly, programs aimed at addressing addiction, which often involve diverse populations, might face cuts. “Quite frankly, if this goes through, we’re going to see an uptick in addiction and overdose,” Fishbein warned, citing the importance of federally funded studies in developing targeted interventions.
Some fear the rule could also stifle innovation in emerging technologies, such as artificial intelligence, by shifting focus away from foundational research. “The peer review process has enabled the U.S. to lead in scientific advancements,” Marvel said. “Without it, we risk losing that edge to other nations.” She added that the current system, while imperfect, has provided a fair and evidence-based approach to funding, fostering trust and progress.
A Battle for Scientific Autonomy
While the OMB defends its changes as necessary to combat political bias, many see them as a broader effort to reshape the scientific landscape. The rule’s implementation would mark a significant departure from the traditional model, where experts evaluate proposals based on their scientific value rather than political alignment. “This is about ensuring that decisions are made by people who understand the complexities of research,” Ouellette argued. “But it’s also about removing the influence of political ideologies from the grantmaking process.”
Opponents of the rule are emphasizing its potential to disrupt the collaborative nature of science. Federally funded international partnerships have been vital in tackling global challenges, from pandemics to climate change. By banning these collaborations, the proposal could isolate the U.S. from critical global dialogue and slow down progress in shared scientific endeavors. “The peer review system has been the backbone of American scientific leadership for decades,” Ginexi said. “If we lose it, we lose the ability to make informed, impartial decisions.”
Public Response and Legal Challenges
The public comment period has become a crucial battleground for scientists and advocates. Over 20,000 submissions are expected, with many focusing on the rule’s impact on diversity in research and its threat to unbiased funding. These comments aim to highlight how the changes could marginalize underrepresented groups and limit the breadth of scientific exploration. “Every single comment is a step toward proving the administration’s approach is flawed,” Ginexi stated.
Legal experts are also weighing in, noting that the rule may face challenges if it is seen as overstepping its authority. The requirement to review and respond to all comments could create opportunities for lawmakers to intervene. Meanwhile, the scientific community continues to push back, arguing that the rule’s emphasis on political oversight could lead to a fragmented and less effective research ecosystem. “This isn’t just about funding—it’s about the future of American science,” Marvel concluded. “If we let politics dictate what gets studied, we risk losing the very foundation of discovery.”
Looking Ahead
As the OMB proposal moves forward, the debate over scientific funding and political influence shows no signs of slowing. The rule’s success will depend on its ability to balance efficiency with fairness, and its potential to reshape research priorities will be tested in the coming months. For now, the fight continues, with scientists and advocates determined to protect the independence that has long defined American scientific achievement. “We’re not just fighting for grants—we’re fighting for the principles that make science thrive,” Ginexi said, underscoring the stakes of the current conflict.
